Chad Williams
Internal Medicine · Charleston, WVNPI 1790170835
Payments from drug & device makers
Across 25 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$96
- Novo Nordisk$94
- AbbVie$52
- Amgen$28
- Mylan Specialty L.p.$23
- Lilly USA, LLC$22
- plus $143 from 8 others
What the payments were for
- Food & beverage$458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $96 |
| Novo Nordisk | 6 | $94 |
| AbbVie(2 entities) | 2 | $52 |
| Amgen | 2 | $28 |
| Mylan Specialty L.p. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Novartis | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Insulet Corporation | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$458 in reported general payments places this provider in the 60th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 68 | $43,423 |
| JardianceEmpagliflozin | 40 | $31,858 |
| FarxigaDapagliflozin Propanediol | 38 | $26,444 |
| EliquisApixaban | 26 | $25,222 |
| MounjaroTirzepatide | 18 | $19,323 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,271 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $4,538 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,923 |
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 12 | $2,164 |
| Duloxetine Hcl | 71 | $1,048 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $943 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $764 |
| Dicyclomine Hcl | 23 | $746 |
| Levothyroxine Sodium | 120 | $612 |
| Insulin Lispro | 13 | $610 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $96 | $34,71451 claims |
| Lilly USA, LLCMounjaro, Insulin Lispro | $22 | $19,93331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 573 internal medicine providers in West Virginia.
Other internal medicine in Charleston
- William ChapmanCharleston$1.7M
- Phillip TriplettCharleston$17K
- Roy BowdenCharleston$14K
- Richard CapitoCharleston$11K
- Ghali Ibrahim-BachaCharleston$9K
- Jack KinderCharleston$8K
- Bradley HenryCharleston$8K
- Brijal PatelCharleston$8K
- William JeffreyCharleston$7K
- Said HajouliCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.